Caris Life Sciences Inc (CAI) Growth Rates Comparisons to Rental & Leasing Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Caris Life Sciences Inc   (NASDAQ: CAI)
    Sector  Services    Industry Rental & Leasing
   Industry Rental & Leasing
   Sector  Services
 

Caris Life Sciences Inc Growth Comparisons

Select each growth Category to receive further Information





CAI Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 45.38 % 7.35 % 8.38 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 21.99 % -4.18 % -2.98 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 96.36 % 4.73 % 6.57 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 9.07 % 1.54 % 2.28 % 2.61 %
Revenue 5 Year Average Growth 22.5 % 13.06 % 11.72 % 10.59 %


CAI's Growth Comparisons in II. Quarter 2026




Strong but slowing Revenue rise by Caris Life Sciences Inc of 45.38% year on year , in the second quarter 2026 to 264 millions, was higher than the 7.35% growth in the Rental & Leasing industry, and 8.38% growth in the Services sector. Despite modest Sales rises in the Services sector and in the Rental & Leasing industry, Caris Life Sciences Inc reported above average market Sales growth.

Company's sequential top-line increase was 21.99% from the first quarter. Average annual sales rise for Caris Life Sciences Inc is 22.5%, while S & P 500's average yearly sales growth is 10.59% over the five years, including only Businesses with the second quarter 2026 Results.

CAI Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Molecular Profiling Services
184.21 %
-
Pharma Research And Development Services
-8.88 %
-
United States
166.82 %
122.32 %
Non-US
-
-
Total
45.38 %
21.99 %


Growth Rates of CAI's Income in the second quarter 2026


CAI Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - 12.59 % 4.17 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) 409.77 % -14.66 % 7.75 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) - 14.65 % -2.62 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) - 1.41 % -1.38 % 20.86 %
Operating Income 5 Year Avg. Change -3.28 % 29.18 % 16.68 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - -83.04 % 2.37 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - 204.04 % 22.47 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) -98.32 % - 6.79 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - 7.64 % 1.62 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - - 54.8 % -28.52 %

CAI Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - -78.95 % -0.64 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) - 384.58 % 30.8 % 27.07 %
Y / Y Net Income Change (Q2 TTM) -98.32 % - 3.77 % 57.33 %
Sequential Net Income Change (Q2 TTM) - 10.54 % -0.09 % 18.65 %
Net Income 5 Year Avg. Growth - - 51.68 % 22.96 %

CAI's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - -85.85 % 2.37 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - 145.03 % 22.47 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - 44.72 % - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - - 54.8 % -28.52 %



CAI EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - -82.43 % -0.64 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) - 290.54 % 30.8 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - 46.6 % - 4.93 %
EPS Net 5 Year Avg. Change - - 51.68 % 22.96 %



Caris Life Sciences Inc reported bottom-line of $ 0.00 in the second quarter, compare to $ -7.97 in the same quarter a year ago. Rental & Leasing industry fell by -82.43%, while Services sector decreased by -0.64%, and overall market improved by 90.69%.

The company's sequential bottom-line increase was 21.99% from the first quarter. Average annual income per share rise for Caris Life Sciences Inc is 22.5%, while S & P 500's average yearly income per share growth is 22.96% over the five years, including only Businesses with the second quarter 2026 earnings results.

CAI Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - 1797.59 % 13.06 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) -71.59 % 33.2 % -10.2 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) - 209.47 % 6.51 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) - 71.6 % -3.11 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 20.12 % 26.25 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) -84.72 % - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - -69.33 % -64.86 % 152.64 %
Net Cash Flow 5 Year Avg. Change - 1.56 % -4.18 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 1492.71 % -34.67 % 0.22 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) 113.45 % -7.43 % -19.5 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) 444.39 % -16.38 % 4.5 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) 86.52 % -8.08 % 0.38 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 21.87 % 18.9 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.